Publication
International arbitration report
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
United States | Publication | November 5, 2021
Federal OSHA published today in the Federal Register its "Emergency Temporary Standard (ETS) to protect more than 84 million workers from the spread of the coronavirus." We provide here the OSHA FAQs documents highlighting the critical provisions and requirements of the ETS.
The ETS compels covered employers to develop and enforce a mandatory COVID vaccination policy unless they adopt a policy requiring employees to choose either vaccination or weekly COVID testing and masking at work.
The ETS covers employers with 100 or more employees – firm- or company-wide – and provides options for compliance. It also requires employers to provide paid time to workers to get vaccinated and paid leave to recover from side effects.
Moreover, the ETS requires employers to:
The ETS does not require employers to pay for testing or face coverings, although employers may be required to pay for testing to comply with other laws, regulations or collective bargaining agreements.
OSHA is offering compliance assistance to implement the standard.
Employers must comply with most ETS requirements within 30 days of today's publication, and within 60 days for testing requirements.
We will report separately on the numerous constitutional and other legal challenges being filed by the multiple states' Attorneys General and business organizations to invalidate the ETS.
Publication
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023